Immediately advise Market Control via the Trading Platform of the following
details:
(a) the identity of the Trading Participant;
(b) the Cash Market Product the subject of the trade;
(c) the number of Cash Market Products;
(d) the price of the trade; and
If you're talking about this, I'm pretty sure "Market Control" isn't us...
Hey FactFinder, why do you seem opposed to Louis being able to sell his shares, to fund his options exercise?
Minimal extra dilution and BRN gets an additional 11 million dollars, as a buffer, before serious cash rolls in.
I still think any employees, would be able to sell shares, unless before reporting periods, or during blackout periods.
It should be a simple answerable question, by the Company, if a blackout period is in place, due to NDAs etc..
But because nothing about them, or any developments, is certain, until realised, I don't think that would be the case..
When Louis did his thing last time, there would have been many things unknown to the general market, that were not certain and therefore, not considered market sensitive.
- Forums
- ASX - By Stock
- BRN
- 2021 BRN Discussion
2021 BRN Discussion, page-2503
-
-
- There are more pages in this discussion • 31,078 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $361.9M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 19.5¢ | $878.2K | 4.371M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 19.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 388739 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
64 | 1444914 | 0.195 |
62 | 1739410 | 0.190 |
33 | 1759832 | 0.185 |
50 | 1530443 | 0.180 |
16 | 598862 | 0.175 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 357097 | 8 |
0.205 | 944687 | 16 |
0.210 | 1398298 | 25 |
0.215 | 506951 | 23 |
0.220 | 758461 | 24 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online